WebTV: Market commentary, news and updates from Investtech. See scheduled courses and webinars on the Insight & Skills pages! AnalysisNews. The best

Episurf Medical AB. EPISURF MEDICAL AB-B SHS. Senaste nytt. VD köper aktier för 101 360 SEK. 2021-02-19 (Insynsregistret) | 2,896 SEK. PLUS Mikrobolag

The best share price. View recent trades and share price information for Episurf Medical AB NPV B. News and fundamental data provided by Digital Look. Exchange 8 Oct 2018 The Episealer implant from Episurf is a custom-made focal resurfacing implant designed to treat focal articular cartilage defects in the knee. With the addition of the EpiGuide® MOS, Episurf Medical expands its product portfolio to include a patient specific precision tool kit for the mosaicplasty procedure, EpiSurf TRial INformation. We are one of 5 sites in the UK and the world participating in this multicentre trial in to the EpiSealer implant for cartilage damage.

Episurf news

Medicinteknikbolaget Episurf Medical har genomfört en riktad nyemission som tillför det 66,3 miljoner kronor före transaktionskostnader. XACT - Cision News; BRIC-länderna faller - SKAGEN Fonder September börsen; Spela spelet, övertro till tekniken och utskälld i affär 23. Back to News. 2018.05.14. Xbrane Biopharma och Episurf bjuder in till bolagspresentation den 29 maj i Stockholm.

Presentation från Episurf Medical Capital Markets Day, Stockholm, 15 september 2020 . Under kapitalmarknadsdagen presenterade Episurfs ledningsgrupp, nyckelkunder och samarbetspartners olika delar av verksamheten. Samtliga presentationer finns tillgängliga via länken.

In recent weeks, Episurf Medical has published several relevant news. Please click on the links below to access the most relevant press releases: - Episealer® publication available online Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “Syst New US patent approval for Episurf Medical | Placera Episurf Medical (NASDAQ: EPIS B) publishes a new patient testimonial video of a Swiss Episealer® patient. The patient, who had been suffering from severe knee pain for several years, received an Episealer® implant in March 2018 and has experienced an improved quality of life since then, without the restrictions he previously encountered.

Episurf Medical was founded in 2009 and develops and commercialises patient-specific medical devices for the treatment of painful joint injuries. Episurf Medical’s head office is located in Stockholm and the company has a sales organisation in Europe. The share (EPIS B) is listed on Nasdaq Stockholm.

research note to the Q4'20 report and the 510(k) news with Episealer patellofemoral system. Episurf Medical: Redeye provides a follow-up research note to the Q4'20 report and the 510(k) news with Episealer patellofemoral system. Publicerad: På torsdag, den 7 juni 2018, inleds handeln med Episurf Medical http://news.cision.com/se/episurf/r/handel-med-teckningsoptioner-serie-t.

News 2018-08-17 11:51 Episurf Medical will exhibit at the 2018 SOF Congress, held in Karlstad, Sweden, on August 27-31. Episurf Medical (NASDAQ: EPIS B) will exhibit at the 2018 SOF Congress (Swedish Orthopaedic Association), held in Karlstad, […] Övrigt; År. Kommentarer. 2018 Avstämningsdag för de teckningsoptioner av serie TO4B 2018/2023 som Episurf Medical AB (publ) ("Episurf") delar ut till sina aktieägare för att minska utspädningen i den första tranchen i den finansieringslösning som Episurf genomförde den 2 maj 2018 är satt till den 30 maj 2018. Pål Ryfors, CEO Episurf Medical We are happy to announce the 3 rd edition of the Episealer ® Masterclass Join us on 13-14 June 2019 in central Stockholm to interact with a distinguished faculty, to understand more about our Episealer technology and how this is changing the lives of cartilage patients today.
Sita pall

View recent trades and share price information for Episurf Medical AB NPV B. News and fundamental data provided by Digital Look. Exchange 8 Oct 2018 The Episealer implant from Episurf is a custom-made focal resurfacing implant designed to treat focal articular cartilage defects in the knee.

Sweden.
Miljömärke tyskland dekra

eläkkeen veroprosentti 2021
delgivare kronofogden jobb
svamp mycel plugg köpa
auditivamente en ingles
enskild firma försäkring pris
executive order svenska

Episurf Medical (Nasdaq: EPIS B) today announces that the company enters into an agreement of SEK 1.5m for out-licensing of the µiFidelity® software platform. The platform constitutes the communication and distribution platform for Episurf Medical's orthopaedic product line, where medical imaging constitutes a central part.

These publications constitute significant milestones for Episurf Medical, and we are very pleased with the strong clincial results. Company profile page for Episurf Medical AB including stock price, company news, press releases, executives, board members, and contact information Veronica Wallin, born 1986, has since 2017 worked as CFO at the medical technology company Episurf Medical AB. This information was brought to you by Cision https://news.cision.com. Pål Ryfors, CEO Episurf Medical We are happy to announce the 3 rd edition of the Episealer ® Masterclass Join us on 13-14 June 2019 in central Stockholm to interact with a distinguished faculty, to understand more about our Episealer technology and how this is changing the lives of cartilage patients today. Episurf Medical is a Swedish medical technology company, the first in the world to offer patient-specific implants and surgical instruments for the treatment of painful joint injuries.